The Diabetic Foot: Neuropathic in Aetiology?
1990; Wiley; Volume: 7; Issue: 10 Linguagem: Inglês
10.1111/j.1464-5491.1990.tb01318.x
ISSN1464-5491
Autores Tópico(s)Pain Mechanisms and Treatments
ResumoDiabetic MedicineVolume 7, Issue 10 p. 852-858 The Diabetic Foot: Neuropathic in Aetiology? A. J. M. Boulton, Corresponding Author A. J. M. Boulton Department of Medicine, Manchester Royal Infirmary, UKDepartment of Medicine, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, UK.Search for more papers by this author A. J. M. Boulton, Corresponding Author A. J. M. Boulton Department of Medicine, Manchester Royal Infirmary, UKDepartment of Medicine, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, UK.Search for more papers by this author First published: December 1990 https://doi.org/10.1111/j.1464-5491.1990.tb01318.xCitations: 59AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 DH Baxter, ed. Kenneth C. McKeown Valedictory Seminar. Chester: Geistlich Education, 1977: 1– 84. 2 Pryce TD. A case of perforating ulcers of both feet associated with diabetes and ataxic symptoms. Lancet 1887; ii: 11– 12. 3 Bild DE, Selby JV, Sinnock P., Browner WS, Braveman P., Showstack JA. Lower-extremity amputation in people with diabetes: epidemiology and prevention. Diabetes Care 1989; 12: 24– 31. 4 Boulton AJM. The diabetic foot. Med Clin North Am 1988; 72: 1513– 1531. 5 Connor H.. The economic impact of diabetic foot disease. In: H. Connor, AJM Boulton, JD Ward, eds. The Foot in Diabetes. Chichester: Wiley, 1987: 145– 149. 6 Boulton AJM, Ward JD. Diabetic neuropathies and pain. Clin Endocrinol Metab 1986; 15: 917– 931. 7 Greene DA, Lattimer SA, Sima AAF. Pathogenesis and prevention of diabetic neuropathy. Diabetes Metab Rev 1988; 4: 201– 221. 8 Vinik A., Mitchell B.. Clinical aspects of diabetic neuropathies. Diabetes Metab Rev 1988; 4: 223– 253. 9 Consensus Statement. Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes 1988; 37: 1000– 1004. 10 Dyck PJ. Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle and Nerve 1988; 11: 21– 32. 11 Young RJ, Ewing DJ, Clarke BF. Chronic and remitting painful polyneuropathy: correlations with clinical features and subsequent changes in neurophysiology. Diabetes Care 1988; 11: 34– 40. 12 Boulton AJM, Knight G., Drury J., Ward JD. The prevalence of symptomatic diabetic neuropathy in an insulin-treated population. Diabetes Care 1985; 8: 125– 128. 13 Young RJ, Maclntyre CCA, Ewing DJ, Prescott RJ. Prediction of neuropathy over 5 years in young insulin-dependent diabetic patients (Abstract). Diabetic Med 1988; 5 (suppl 1): 7. 14 Boulton AJM, Worth RC, Drury J., et al. Genetic and metabolic studies in diabetic neuropathy. Diabetologia 1984; 26: 15– 19. 15 Bianchi R., Marelli C., Marini P., et al. Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. Diabetologia 1990: 33: 131– 136. 16 Calcutt NA, Tomlinson DR, Biswas S.. Coexistence of nerve conduction deficit with increased Na+-K+-ATPase activity in galactose-fed mice. Diabetes 1990; 39: 663– 666. 17 Boulton AJM, Levin S., Comstock J.. A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy. Diabetologia 1990; 33: 431– 437. 18 Greene DA, Sima AAF. Biochemical and morphometric response to tolrestat in human diabetic nerve (Abstract). Diabetologia 1990; 33 (in press). 19 Masson EA, Boulton AJM. Aldose reductase inhibitors in the treatment of diabetic neuropathy. Drugs 1990; 39: 190– 202. 20 Fagerberg SE. Diabetic neuropathy: a clinical and histologic study on the significance of vascular affections. Acta Med Scand 1959; suppl 345: 1– 80. 21 Timperley WR, Boulton AJM, Davies-Jones GAB, Jarratt JA, Ward JD. Small vessel disease in progressive diabetic neuropathy with good metabolic control. J Clin Path 1985; 38: 1030– 1038. 22 Newrick PG, Wilson AJ, Jacubowski J., Boulton AJM, Ward JD. Sural nerve oxygen tension in human diabetes. Br Med J 1986; 293: 1053– 1054. 23 Low PA. Recent advances in the pathogenesis of diabetic neuropathy. Muscle and Nerve 1987; 10: 121– 128. 24 Tuck RR, Schmelzer JD, Low PA. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984; 107: 935– 950. 25 Yao JK, Low PA. Improvement of endoneurial lipid abnormalities in experimental diabetic neuropathy by oxygen modification. Brain Res 1986; 362: 362– 365. 26 Low PA, Schmelzer JD, Ward KK, Yao JK. Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am J Physiol 1986; 250: E94– E99. 27 Masson EA, Church SE, Woodcock AA, Hanley SP, Boulton AJM. Is resistance to ischaemic conduction failure induced by hypoxia? Diabetologia 1988; 31: 762– 765. 28 Malik RA, Masson EA, Sharma AK, et al. Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia 1990; 33: 311– 318. 29 Nielubowicz J., Borkowski M., Baraniewski H.. Opening of arteriovenous anastomoses and trophic ulcer formation after peripheral nerve injury. J Cardiovasc Surg 1974; 15: 636– 646. 30 Boulton AJM, Kubrusly DB, Bowker JH, et al. Impaired vibratory perception and diabetic foot ulceration. Diabetic Med 1986; 3: 335– 337. 31 Edmonds ME. Experience in a multi-disciplinary diabetic foot clinic. In: H. Connor, AJM Boulton, JD Ward, eds. The Foot in Diabetes. Chichester: Wiley, 1987: 121– 133. 32 Thomson F., Masson EA, Veves A., et al. The impact of a multi-disciplinary approach to diabetic foot problems. Diabetologia 1990; 33 (in press). 33 Young RJ, Zhou YQ, Rodriguez E., et al. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes 1986; 35: 192– 197. 34 Deanfield JE, Daggett PR, Harrison MJG. The role of autonomic neuropathy in diabetic foot ulceration. J Neurol Sci 1980; 43: 203– 210. 35 Edmonds ME, Nicolaides KH, Watkins PJ. Autonomic neuropathy and diabetic foot ulceration. Diabetic Med 1986; 3: 56– 59. 36 Boulton AJM, Hardisty CA, Betts RP, et al. Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 1983; 6: 26– 33. 37 Partsch H.. Neuropathies vom utero-mutilierenden. Vasa 1977; 6 (suppl): 1– 48. 38 Boulton AJM, Scarpello JHB, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia 1982; 22: 6– 8. 39 Edmonds ME, Roberts UC, Watkins PJ. Blood flow in the diabetic neuropathic foot. Diabetologia 1982; 22: 9– 15. 40 Flynn MD, Edmonds ME, Tooke JE, Watkins PJ. Direct measurement of capillary blood flow in the diabetic neuropathic foot. Diabetologia 1988; 31: 652– 656. 41 Kosiak M.. Etiology and pathology of ischemic ulceration. Arch Phys Med Rehab 1959; 40: 62– 69. 42 Barrett JP, Mooney V.. Neuropathy and diabetic pressure lesions. Orthop Clin North Am 1973; 4: 43– 47. 43 Stokes IAF, Faris I., Hutton WC. The neuropathic ulcer and loads on the foot in diabetic patients. Acta Orthop Scand 1975; 46: 839– 847. 44 Duckworth T., Betts RP, Franks CI, Burke J.. The measurement of pressure under the foot. Foot Ankle 1982; 3: 130– 141. 45 Boulton AJM, Betts RP, Franks CI, et al. Abnormalities of foot pressure in early diabetic neuropathy. Diabetic Med 1987; 4: 225– 228. 46 Boulton AJM, Franks CI, Betts RP, Duckworth T., Ward JD. Reduction of abnormal foot pressures in diabetic neuropathy using a new polymer insole material. Diabetes Care 1984; 7: 42– 46. 47 Duckworth T., Boulton AJM, Betts RP, Franks CI, Ward JD. Plantar pressure measurement and the prevention of ulceration in the diabetic foot. J Bone Joint Surg 1985; 67B: 79– 85. 48 Boulton AJM, Betts RP, Franks CI, Ward JD, Duckworth T.. The natural history of foot pressure abnormalities in neuropathic diabetic subjects. Diabetes Res 1987; 5: 73– 77. 49 Cochrane T., Sheriff SB, Boulton AJM, Ward JD, Atkins RM. Laser doppler flowmetry in the assessment of peripheral vascular disorders: a preliminary evaluation. Clin Phys Physiol Meas 1986; 7: 31– 42. 50 Newrick PG, Cochrane T., Betts RP, Ward JD, Boulton AJM. Reduced hyperaemic response under the diabetic neuropathic foot. Diabetic Med 1988; 5: 570– 573. 51 Masson EA, Hay EM, Stockley I., Veves A., Betts RP, Boulton AJM. Abnormal foot pressures alone may not cause ulceration. Diabetic Med 1989; 6: 426– 428. 52 Boulton AJM. Diabetic neuropathy and foot ulceration ( MD Thesis). Newcastle upon Tyne: University of Newcastle upon Tyne, 1985. 53 Campbell RR, Hawkins SJ, Maddison PJ, Reckless JPD. Limited joint mobility in diabetes mellitus. Ann Rheum Dis 1985; 44: 93– 97. 54 Jennings AM, Milner PC, Ward JD. Hand abnormalities are associated with the complications of Type 2 diabetes. Diabetic Med 1989; 6: 43– 47. 55 Delbridge L., Perry P., Marr S., et al. Limited joint mobility in the diabetic foot: relationship to neuropathic ulceration. Diabetic Med 1988; 5: 333– 337. 56 Fernando DJS, Masson EA, Veves A., Boulton AJM. Limited joint mobility: relationship to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1990 (in press). 57 Herring KM, Richie DH. Friction blisters and sock fiber composition. J Am Pod Assoc 1990; 80: 63– 71. 58 Veves A., Masson EA, Fernando DJS, Boulton AJM. Use of experimental hosiery to reduce abnormal foot pressure in diabetic neuropathy. Diabetes Care 1989; 12: 653– 655. 59 Veves A., Masson EA, Fernando DJS, Boulton AJM. Studies of experimental hosiery in diabetic neuropathic patients with high foot pressures. Diabetic Med 1990; 7: 324– 326. Citing Literature Volume7, Issue10December 1990Pages 852-858 ReferencesRelatedInformation
Referência(s)